Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Drug crawled time : 18:00 save search
Biden Turns Up Heat on Big Pharma’s Drug Prices in State of the Union Address
Published: 2024-03-08 (Crawled : 18:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.68%
H: 0.0%
C: 0.0%
drug state
Bruker Introduces the Ingenious Novel ‘Triceratops’ SPR #64 Surface Plasmon Resonance System for Drug Discovery at SLAS2024
Published: 2024-02-05 (Crawled : 18:00) - biospace.com/
BRKR | $77.725 -1.06% -1.07% 1.3M
|
Health Technology
|
| O: -0.4%
H: 0.82%
C: -0.08%
slas2024 drug system
Breast Cancer Therapeutics Market 2023, USD 15.64 billion Growth is Expected between 2023 to 2028, Robust pipeline and new drug approvals to Boost Growth - Technavio
Published: 2024-01-30 (Crawled : 18:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 5.68%
H: 0.77%
C: 0.77%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 3.41%
H: 0.0%
C: -2.45%
VTRS A | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: -0.08%
H: 3.47%
C: -0.25%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -2.04%
H: 0.19%
C: -1.97%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 4.04%
H: 1.57%
C: -3.02%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.5%
H: 0.07%
C: -0.81%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.75%
H: 0.0%
C: 0.0%
PBYI | $5.01 0.4% 0.4% 290K
|
Health Technology
|
| O: -0.1%
H: 2.31%
C: -1.26%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 0.82%
H: 0.12%
C: -1.64%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.44%
H: 0.2%
C: -0.55%
drug breast expected cancer pipeline therapeutics growth market
Drug Screening Market Forecast to Reach $15.04 Billion by 2028 … – Business Wire
Published: 2024-01-18 (Crawled : 18:00) - spacfeed.com
KGS | $27.01 2.08% 0.0% 340K
|
n/a
|
| O: 1.03%
H: 0.51%
C: 0.46%
drug business reach market
Global EYLEA Drug Market Size to Surpass US$ 14.30 Billion by 2030 | Exhibiting a CAGR of 7.2% : CoherentMI
Published: 2024-01-16 (Crawled : 18:00) - prnewswire.com
REGN | $896.27 0.26% 0.25% 500K
|
Health Technology
|
| O: 0.26%
H: 0.34%
C: -1.13%
CHRS | $2.06 3.0% 2.91% 2.9M
|
Health Technology
|
| O: -1.28%
H: 8.19%
C: 6.03%
drug eylea global market
Enveric Biosciences Updates Key Data Underpinning Selection of EB-003 as Lead Drug Candidate from EVM301 Series
Published: 2024-01-03 (Crawled : 18:00) - biospace.com/
ENVB | $0.8989 -4.17% -4.35% 130K
|
Health Technology
|
| O: 6.35%
H: 0.0%
C: -1.49%
eb-003 drug candidate series evm301
Biological Drug API Manufacturing Services Market Report 2023-2033 - Single Use Technology will Become Essential Over the Next Decade
Published: 2023-12-28 (Crawled : 18:00) - prnewswire.com
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
CTLT | $55.48 -0.57% -0.4% 1.6M
|
Health Technology
|
| O: -0.26%
H: 1.19%
C: 0.35%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.75%
H: 0.24%
C: -0.32%
drug services report technology market
Weight Loss Treatment: SciSparc’s Obesity Drug Showed Positive Results in a Pre-Clinical Trial
Published: 2023-12-01 (Crawled : 18:00) - globenewswire.com
CMND | $1.22 3.56% 3.43% 110K
|
n/a
|
| O: 20.86%
H: 21.75%
C: -2.13%
SPRC | $1.235 -4.26% -4.45% 150K
|
Manufacturing
|
| O: 22.92%
H: 2.08%
C: -17.08%
obesity drug pre-clinical positive trial results
Global Cyclin-Dependent Kinase Inhibitor Drug Research Report 2023: Comprehensive Analysis of 45 Companies and 50+ Pipeline Drugs
Published: 2023-11-21 (Crawled : 18:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.44%
H: 0.63%
C: -0.05%
drug companies report pipeline research global
Kadcyla Leads the Global Antibody Drug Conjugates Market with Extensive Use in Breast Cancer Treatment
Published: 2023-11-01 (Crawled : 18:00) - prnewswire.com
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: -1.46%
H: 3.67%
C: 3.26%
ZYME | $8.85 2.08% 2.03% 550K
|
Health Technology
|
| O: 1.14%
H: 0.42%
C: -0.7%
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 1.03%
H: 0.73%
C: 0.58%
ADCT | $4.72 -0.84% 0.0% 320K
|
Health Technology
|
| O: -0.16%
H: 6.42%
C: 4.49%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.86%
H: 0.0%
C: 0.0%
STRO | $3.635 -3.58% -3.71% 520K
|
Health Technology
|
| O: 0.39%
H: 3.86%
C: 3.86%
IMGN | $31.23 0.03% 49M
|
Health Technology
|
| O: 5.09%
H: 5.48%
C: -1.27%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.47%
H: 1.88%
C: 1.78%
EXEL | $22.51 0.09% 0.09% 2.3M
|
Health Technology
|
| O: -2.62%
H: 1.17%
C: -1.66%
drug antibody breast cancer treatment global market
U.S. Food and Drug Administration (FDA) Approves FoundationOne®CDx as a Companion Diagnostic for Lilly’s Retevmo® (selpercatinib) for Certain Patients with Solid Tumors
Published: 2023-10-09 (Crawled : 18:00) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.21%
H: 2.8%
C: 1.37%
foundationone drug diagnostic food tumors companion
Kiora Pharmaceuticals Receives Investigational New Drug Application Approval to Expand Phase 1b Study of KIO-301 in Inherited Retinal Diseases; To Enroll Patients with Choroideremia and Additional Patients with Late-Stage Retinitis Pigmentosa
Published: 2023-10-03 (Crawled : 18:00) - biospace.com/
KPRX | $0.502 -1.57% -1.59% 49K
|
Manufacturing
|
| O: 0.0%
H: 3.03%
C: -1.69%
kio-301 drug approval pharmaceuticals enroll application study
New Report Reveals Trends, Opportunities in Drug Development
Published: 2023-09-25 (Crawled : 18:00) - ppdi.com
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
|
| O: -0.72%
H: 0.0%
C: 0.0%
drug report
Approximately 30% Of Newly Diagnosed Cancers In Women Will Be Breast Cancers - Atossa Therapeutics Has A Promising Drug To Help With Prevention And Treatment
Published: 2023-09-18 (Crawled : 18:00) - biospace.com/
ATOS | $1.37 -3.52% -3.65% 1.2M
|
Health Technology
|
| O: -1.33%
H: 2.56%
C: 2.03%
drug breast treatment women therapeutics
AstraZeneca Latest to Sue Biden Administration Over IRA’s Drug Price Negotiat...
Published: 2023-08-28 (Crawled : 18:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.1%
H: 0.0%
C: 0.0%
drug
Exploring RNAi Drug Delivery Innovations in the Global Market 2023-2028 - Unveiling Orphan Drug Opportunities and Novel Nanoparticle Delivery Breakthroughs
Published: 2023-08-24 (Crawled : 18:00) - prnewswire.com
SLN | $22.75 3.32% 3.21% 310K
|
Health Technology
|
| O: 4.41%
H: 4.45%
C: 2.45%
PHIO | $0.631 -1.07% -1.08% 29K
|
Health Technology
|
| O: 0.43%
H: 0.86%
C: 0.86%
drug global market
Biomica Opens Second Site to Advance Its Immuno-Oncology Drug Trials at Davidoff Center
Published: 2023-08-15 (Crawled : 18:00) - biospace.com/
EVGN | $0.7 -13.64% 63K
|
Health Technology
|
| O: 2.5%
H: 0.0%
C: -5.24%
drug trials
Addressing Unmet Needs: Uveitis Market Report Provides Opportunities for Drug Developers
Published: 2023-08-03 (Crawled : 18:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.53%
H: 0.0%
C: 0.0%
drug report market
Antibody Drug Conjugate - Competitive Landscape 2023 Study: Featuring Coverage on 180+ Companies and 300+ Drugs
Published: 2023-06-30 (Crawled : 18:00) - prnewswire.com
SRNE | $0.024 -8.85% 57K
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
| Email alert
Add to watchlist
IMGN | $31.23 0.03% 49M
|
Health Technology
| Email alert
Add to watchlist
FNCTF | News | $11.0354 -20.84% 320
|
Communications
| Email alert
Add to watchlist
drug companies antibody
Zealand Pharma submits New Drug Application to US FDA for dasiglucagon in congenital hyperinsulinism
Published: 2023-06-30 (Crawled : 18:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 2.23%
H: 0.97%
C: 0.81%
fda pharma drug application
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.